Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019 in Miami
Alberto Santagostino, Lonza's SVP Cell and Gene Technologies delivers an invigorating keynote presentation at Phacilitate Leaders World Miami where he explores the considerations and potential of industrialising advanced therapies.
Watch the video below to hear Alberto discuss the sources of innovation in the advanced therapies industry, illustrated with some interesting data. He also outlines the critical path for cell and gene therapies vs traditional therapies and why thinking about process development and manufacturability early on this path is essential to avoiding setbacks when it comes to regulatory submissions.
You will also hear more about demand forecasting in comparison to traditional therapies, mass customisation and driving improvements in three dimensions to produce synergistic results.